{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-22-000506","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2022-03-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.416844+00:00","generated_at":"2026-06-26T22:22:44.007082+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Artelo Biosciences gets second 180-day Nasdaq extension to meet $1 minimum bid price","bullets":["Nasdaq granted second 180-day period until September 12, 2022 to regain compliance with bid price rule.","Failure to comply by deadline will result in delisting notice; company may appeal to hearings panel.","Company plans to monitor closing bid price and consider available options to regain compliance.","Stock trades under ticker ARTL on Nasdaq; minimum bid price requirement is $1.00."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-22-000506","json":"https://secwatch.observer/filing/0001640334-22-000506.json","markdown":"https://secwatch.observer/filing/0001640334-22-000506.md","text":"https://secwatch.observer/filing/0001640334-22-000506.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033422000506/0001640334-22-000506-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033422000506/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T22:22:44.007082+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}